Human Biospecimen

Mycophenolic acid glucuronide (MPA-G)

Mycophenolic acid glucuronide (MPA-G)

TDMPlasma, Serum
Sample Reference:C60363
Source Origin:Overseas origin

Specimen Profile

Key information about this biospecimen.

Marker / Cohort
Mycophenolic acid glucuronide (MPA-G)
Disease Category
TDM
Matrix
Plasma, Serum
Sample Reference
C60363
Source Origin
Overseas origin
Availability
Available to source
Intended Use
Research & IVD Development
Supply Status
Specification confirmed per project

About Mycophenolic acid glucuronide (MPA-G)

Human biospecimens for projects involving Mycophenolic acid glucuronide (MPA-G).

Sourcing Options

Reliable sourcing network and project-based documentation.

Standard Samples

Current sourceable options can be checked against your specification.

Bulk Supply

Bulk-volume sourcing may be available depending on marker, matrix and project requirements.

Custom / Prospective Collection

For projects requiring defined donor, matrix or collection criteria.

Matched / Paired Samples

Matched or longitudinal sets (e.g. disease/healthy, pre/post) can be discussed where feasible.

Define Your Requirement

Tell us the specification you need. Our team will check current sourcing options for you.

Requesting: Mycophenolic acid glucuronide (MPA-G)|Ref: C60363

Not sure about the specification?

Our technical team can help you define the most suitable matrix, titre range, donor profile or other project requirements.

Your information will only be used for this inquiry and handled in confidence.

Sourcing & Documentation

Overseas sourcing route available

We work with trusted international partners to source high-quality biospecimens.

Source verification

Source and specification are confirmed for each project.

Documentation available by project

Supporting documentation may include matrix details, donor/cohort information, test-related or characterization information where applicable.

Supporting documentation is confirmed according to the current source and project requirements.

Intended Use & Compliance

For Research & IVD Development Use

Human biospecimens are supplied for research and IVD development purposes and are not intended for direct human use. Availability and China import eligibility are reviewed based on specimen type, source, intended use and project requirements.

Partner with XIAOPROTEIN

Need a Different Specification?

Looking for another matrix, titre range, donor profile or collection requirement? Tell us what you need.

Marker / Disease Cohort

Mycophenolic acid glucuronide (MPA-G)

Matrix Options

Plasma; Serum

Overview

What is this product?

MPA-glucuronide specimen cohort for mycophenolate metabolism, assay-specificity and TDM method-development studies.

Mycophenolic-acid glucuronide is a major metabolite relevant to assay specificity and pharmacokinetic interpretation; therapeutic monitoring focuses primarily on the active parent MPA exposure. Matrix option(s): Plasma; Serum. For assay development or validation, confirm the exact cohort/analyte definition, collection timing, handling conditions, lot availability and project-specific use restrictions.

Specimen Considerations

Sample handling considerations

Matrix option(s): Plasma; Serum. Confirm specimen type/anticoagulant, collection timing, donor phenotype or disease definition, analyte positivity/level where relevant, freeze–thaw history, volume, treatment status and assay-specific acceptance criteria.

Technical Characteristics

Sample Information

Marker / Disease Cohort

Mycophenolic acid glucuronide (MPA-G)

Disease Areas

TDM

Matrix

Plasma; Serum

Application Workflow

Sample position in workflow

Collection

Characterization

Validation

鄂ICP备2026055791号-1